These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35182806)

  • 1. A de novo and novel nonsense variants in ASXL2 gene is associated with Shashi-Pena syndrome.
    Jiao Z; Zhao X; Wang Y; Wei E; Mei S; Liu N; Kong X; Shi H
    Eur J Med Genet; 2022 Apr; 65(4):104454. PubMed ID: 35182806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newborn with a pathogenic variant in ASXL2 expanding the phenotype of SHAPNS: a case report and literature review.
    Yuan M; Shan Y; Xu F; Yang L; Sun C; Cheng R; Wu B; Zhang Z; Cao Y; Zhang R; Zhou W; Cheng G; Hu L
    Transl Pediatr; 2023 Jan; 12(1):86-96. PubMed ID: 36798937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.
    Cuddapah VA; Dubbs HA; Adang L; Kugler SL; McCormick EM; Zolkipli-Cunningham Z; Ortiz-González XR; McCormack S; Zackai E; Licht DJ; Falk MJ; Marsh ED
    Am J Med Genet A; 2021 Jun; 185(6):1700-1711. PubMed ID: 33751773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepubertal onset of type 2 diabetes in Shashi-Pena syndrome due to ASXL2 mutation.
    Murphy SA; O'Rourke NE; O'Grady MJ
    Am J Med Genet A; 2022 Sep; 188(9):2803-2807. PubMed ID: 35716351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
    Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
    Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral findings and healthcare management in Shashi-Pena syndrome.
    Alqaisi D; Hassona Y
    Spec Care Dentist; 2022 Jul; 42(4):432-436. PubMed ID: 34902171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Shashi-Pena Syndrome Caused by Chromosomal Rearrangement Using Nanopore Sequencing.
    Wang Y; Tan J; Wang Y; Liu A; Qiao F; Huang M; Zhang C; Zhou J; Hu P; Xu Z
    Neurol Genet; 2021 Dec; 7(6):e635. PubMed ID: 34841066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx.
    Baskind HA; Na L; Ma Q; Patel MP; Geenen DL; Wang QT
    PLoS One; 2009; 4(3):e4750. PubMed ID: 19270745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
    Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
    J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of adult cardiac function requires the chromatin factor Asxl2.
    Lai HL; Grachoff M; McGinley AL; Khan FF; Warren CM; Chowdhury SA; Wolska BM; Solaro RJ; Geenen DL; Wang QT
    J Mol Cell Cardiol; 2012 Nov; 53(5):734-41. PubMed ID: 23046516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.
    Park UH; Kang MR; Kim EJ; Kwon YS; Hur W; Yoon SK; Song BJ; Park JH; Hwang JT; Jeong JC; Um SJ
    Oncogene; 2016 Jul; 35(28):3742-52. PubMed ID: 26640146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets.
    Lai HL; Wang QT
    PLoS One; 2013; 8(9):e73983. PubMed ID: 24040135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse genome-wide association and systems genetics identify Asxl2 as a regulator of bone mineral density and osteoclastogenesis.
    Farber CR; Bennett BJ; Orozco L; Zou W; Lira A; Kostem E; Kang HM; Furlotte N; Berberyan A; Ghazalpour A; Suwanwela J; Drake TA; Eskin E; Wang QT; Teitelbaum SL; Lusis AJ
    PLoS Genet; 2011 Apr; 7(4):e1002038. PubMed ID: 21490954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulator ASXL2: Structure, Function and its Predictive Value in Diseases.
    Li M; Xu L; Zhang R; Dong C
    Curr Protein Pept Sci; 2023; 24(1):22-30. PubMed ID: 36503466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
    Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of ASXL3 gene in silico.
    Katoh M; Katoh M
    Int J Oncol; 2004 Jun; 24(6):1617-22. PubMed ID: 15138607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Relationship between ASXL2 and ZBTB7A Gene Mutations and Prognosis in Patients with Acute Myeloid Leukemia].
    Cao HQ; Tuo JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):450-455. PubMed ID: 33812414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
    Kawashima N; Akashi A; Nagata Y; Kihara R; Ishikawa Y; Asou N; Ohtake S; Miyawaki S; Sakura T; Ozawa Y; Usui N; Kanamori H; Ito Y; Imai K; Suehiro Y; Kitamura K; Sakaida E; Takeshita A; Suzushima H; Naoe T; Matsumura I; Miyazaki Y; Ogawa S; Kiyoi H;
    Ann Hematol; 2019 Jan; 98(1):83-91. PubMed ID: 30251205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WTIP interacts with ASXL2 and blocks ASXL2-mediated activation of retinoic acid signaling.
    Khan FF; Li Y; Balyan A; Wang QT
    Biochem Biophys Res Commun; 2014 Aug; 451(1):101-6. PubMed ID: 25065743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.